I am a Consultant Anaesthetist who specialises in pain medicine. This is a sub-specialty that is affiliated to the Royal College of Anaesthetists, but is under its own faculty. I have been an interventional pain management consultant since 2007, and my NHS practice is at Stepping Hill Hospital where I am Clinical Lead for the Chronic Pain Service.
I work closely with OrthTeam Centre neurosurgical and orthopaedic specialists to jointly oversee and manage patients, ensuring that the best outcome is achieved. I have access to fortnightly multidisciplinary (MDT) spinal team meetings, where we can discuss individual cases and advise on the best management.
My areas of interest mainly focus around non-surgical techniques to reduce spinal and more recently shoulder pain. These techniques involve X-ray or ultrasound guided interventions for short term 'acute' problems such as sciatica or more radiofrequency denervations of small nerves to reduce transmission of pain for certain longer term 'chronic' conditions.
Radiofrequency treatment is an evolving treatment which I now have extensive experience of and we have leading technology available at the OrthTeam Centre to allow us to do this safely and effectively.
I have extensive experience in pain medicine interventions, undertaking over 200 injection-based treatments each year. My expertise allows me to understand the patient's pain and assess their condition to advise on injection-based treatments and how they might reduce symptoms.
Qualifications: MBBS (London), FRCA, FCARCSI, FFPMRCA
After completing Medical School in London, I joined the British Army for six years serving as a Medical Officer in the Infantry. I then started specialty training in anaesthesia but kept an interest in musculoskeletal pain after my time in the military, which led to my undertaking advanced pain training in the North West. As a consultant I have been able to continue to develop my interest in interventions to try and reduce pain and improve movement, particularly for back pain as some patients respond well to targeted treatment.